Thalassaemia trials in China
6 of 28 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleGrowth and Development-related Outcomes in Children With Transfusion-dependent Beta-thalassemia After Gene Therapy
- Where
- Tianjin
- Age
- 3 years to 14 years
- People
- 100
- Run by
- Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT05991336 - No phaseTaking peopleLow-Dose Liposomal Amphotericin B for Invasive Fungal Infection Prophylaxis in Neutropenic Children
- Where
- Haikou
- Age
- 3 years to 17 years
- People
- 30
- Run by
- Haikou Affiliated Hospital of Central South University Xiangya School of Medicine
See details and how to joinNCT07725263 - No phaseTaking peopleLong-term Follow-up Study of BRL-101 for TDT
- Where
- Changsha, Guangxi, Guangzhou, Nanning, Shenzhen, Tianjin
- Age
- 3 years to 35 years
- People
- 45
- Run by
- Bioray Laboratories
See details and how to joinNCT06298630 - No phaseEnrolling by invitationA Long-term Follow-up Study in Participants Who Received CS-101
- Where
- Nanning
- Age
- 6 years to 35 years
- People
- 5
- Run by
- CorrectSequence Therapeutics Co., Ltd
See details and how to joinNCT06685536 - No phaseEnrolling by invitationA Follow-up Study to Evaluate the Long-term Safety and Efficacy in Participants Who Received CS-101 Injection
- Where
- Nanning
- Age
- 12 years to 35 years
- People
- 8
- Run by
- CorrectSequence Therapeutics Co., Ltd
See details and how to joinNCT06717932 - No phaseTaking peopleLong-term Follow-up Study of BHC001 for TDT
- Where
- Changsha, Nanning
- Age
- 5 years to 35 years
- People
- 6
- Run by
- Bioray Laboratories
See details and how to joinNCT06314529